H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair
Antioxidants · 19.11.2026 · 15 (11) · 1504
DOI: 10.3390/antiox15111504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 19.11.2026. Verfasst von Pierfrancesco Cinque und 22 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Farmaceutici Damor S.p.A..
Abstract (Originalsprache)
To integrate complementary pharmacological properties relevant to cutaneous wound repair, we designed and synthesized six novel molecular hybrids combining a JAK1-targeting 7H-pyrrolo[2,3-d]pyrimidine scaffold with selected hydrogen sulfide (H2S)-releasing moieties. The compounds were characterized for their H2S-releasing properties and evaluated in human HaCaT keratinocytes, using abrocitinib, a selective JAK1 inhibitor, as a reference compound. Compounds II, III, and V emerged as the most promising derivatives, displaying marked pro-migratory activity in both scratch wound and Transwell assays, with effects exceeding those of the corresponding H2S donors and abrocitinib under the tested conditions. Notably, compounds II, III, and V exhibited distinct cysteine-dependent H2S-release profiles, characterized by a progressive increase followed by a relatively stable plateau during the 30-min amperometric assay performed at 100 µM. Molecular docking studies supported the ability of the selected hybrids to retain key interactions within the JAK1 binding pocket, while highlighting linker-dependent differences in ligand orientation. Further biological characterization showed that compounds II and V modulated the expression of the extracellular matrix-related genes COL1A1, MMP2, and MMP9, whereas compounds II, III, and V attenuated IFN-γ/TNF-α-induced STAT1 phosphorylation with effects comparable to abrocitinib. Under inflammatory conditions, compounds II and V also counteracted the cytokine-induced reduction in COL1A1 expression. Overall, these findings identify compounds II, III, and V as promising multifunctional H2S-releasing molecular hybrids and support the development of H2S-based hybrid pharmacological strategies combining H2S-releasing properties with enhanced keratinocyte migration, modulation of extracellular matrix-related responses, and attenuation of cytokine-induced STAT1 activation.
Förderung
- Farmaceutici Damor S.p.A.
Zitieren
APA
Cinque, P., Somma, F., Romano, B., Caliendo, G., Santagada, V., Perissutti, E., Magli, E., Vertuccio, S., Andreozzi, G., Sparaco, R., Severino, B., Fiorino, F., Dani, L., Citi, V., Martelli, A., Calderone, V., Palladino, R., Romano, E., Ciriaco, L., …, & Frecentese, F. (2026). H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair. Antioxidants, 15(11), 1504. https://doi.org/10.3390/antiox15111504
Vancouver
Cinque P, Somma F, Romano B, Caliendo G, Santagada V, Perissutti E, et al. H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair. Antioxidants. 2026;15(11):1504. doi:10.3390/antiox15111504
BibTeX
@article{Cinque2026,
author = {Cinque, Pierfrancesco and Somma, Fabio and Romano, Benedetta and Caliendo, Giuseppe and Santagada, Vincenzo and Perissutti, Elisa and Magli, Elisa and Vertuccio, Stefania and Andreozzi, Giorgia and Sparaco, Rosa and Severino, Beatrice and Fiorino, Ferdinando and Dani, Letizia and Citi, Valentina and Martelli, Alma and Calderone, Vincenzo and Palladino, Roberta and Romano, Eugenia and Ciriaco, Lidia and Maglione, Barbara and Ercolano, Giuseppe and Ianaro, Angela and Frecentese, Francesco},
title = {H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {11},
pages = {1504},
doi = {10.3390/antiox15111504}
}
EUVIMED